financetom
Business
financetom
/
Business
/
Aura Minerals Q2 Production Holds Steady YoY; Strikes Subscription Agreement with Altamira Gold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aura Minerals Q2 Production Holds Steady YoY; Strikes Subscription Agreement with Altamira Gold
Jul 4, 2025 3:15 AM

05:56 AM EDT, 07/04/2025 (MT Newswires) -- Aura Minerals ( ORAAF ) late on Thursday released second-quarter preliminary production results from its operating mines and entered into a subscription agreement with Altamira Gold ( EQTRF ) .

Total production from the Aranzazu, Apoena, Minosa, Almas and Borborema mines amounted to 64,033 gold equivalent ounces, a 7% increase from the previous quarter and in line with year-ago levels.

At constant prices, Aura's production rose 9% compared with both the first quarter of 2025 and the second quarter of 2024.

Compared with year-ago levels, output from Aranzazu fell 10% to 22,281 GEOs, Apoena output declined 17% to 8,219 GEOs and Minosa production dropped 6% to 18,039 GEOs. Production from Almas jumped 22% to 12,917 GEOs.

The Borborema mine produced 2,577 GEOs following its first gold pour. The company said Borborema remains on track to declare commercial production by the end of the third quarter.

Separately, Aura said it signed a subscription agreement with Altamira, under which it acquired 6 million units of Altamira in a non-brokered private placement at $0.10 per unit for a total of $600,000.

Each unit consists of one common share and one-half of one common share purchase warrant exercisable to acquire one Altamira share at an exercise price of $0.15 apiece until June 30, 2027.

Before the agreement, Aura held 24 million shares and 24 million warrants, representing about 20.3% of the issued and outstanding shares on a fully diluted basis.

Upon closing of the private placement, Aura holds 30 million shares and 27 million warrants, representing approximately 19.5% of the shares on a fully diluted basis.

Aura said it acquired the units as an investment given the exploration potential of Altamira.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved